Boston Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $406K | Sell |
|
|||||
|
2024
Q3 | $2.01M | Buy |
|
|||||
|
2024
Q2 | $915K | Buy |
|
|||||
|
2024
Q1 | $410K | Sell |
|
|||||
|
2023
Q4 | $587K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.72M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $4.71M | Buy |
|
|||||
|
2017
Q1 | $3.43M | Sell |
|
|||||
|
2016
Q4 | $58.2M | Sell |
|
|||||
|
2016
Q3 | $90.5M | Sell |
|
|||||
|
2016
Q2 | $101M | Sell |
|
|||||
|
2016
Q1 | $242M | Buy |
|
|||||
|
2015
Q4 | $244M | Sell |
|
|||||
|
2015
Q3 | $282M | Sell |
|
|||||
|
2015
Q2 | $517M | Sell |
|
|||||
|
2015
Q1 | $560M | Sell |
|
|||||
|
2014
Q4 | $529M | Buy |
|
|||||
|
2014
Q3 | $419M | Buy |
|
|||||
|
2014
Q2 | $152M | Buy |
|
|||||
|
2014
Q1 | $6.03M | Sell |
|
|||||
|
2013
Q4 | $5.04M | Hold |
|
|||||
|
2013
Q3 | $4.75M | Sell |
|
|||||
|
2013
Q2 | $8.43M | Buy |
|